Association between atherogenic index of plasma and future cardiovascular disease risk in middle-aged and elderly individuals with cardiovascular-kidney-metabolic syndrome stage 0-3

被引:1
作者
Lin, Ya [1 ]
Lv, Xiaodong [2 ]
Shi, Ce [3 ]
Wang, Ting [4 ]
Jin, Zehao [5 ]
Jin, Qiangsong [6 ]
Gu, Chao [2 ]
机构
[1] Wenzhou Med Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Jiaxing Univ, Affiliated Hosp, Hosp Jiaxing 1, Dept Resp Med, Jiaxing, Zhejiang, Peoples R China
[3] Wenzhou Vocat Coll Sci & Technol, Sch Digital Econ, Wenzhou, Zhejiang, Peoples R China
[4] Shaoxing Peoples Hosp, Dept Ultrasound, Shaoxing, Zhejiang, Peoples R China
[5] Tech Univ Munich, Sch Med & Hlth, Munich, Germany
[6] Zhejiang Univ, Affiliated Jinhua Hosp, Sch Med, Dept Cardiol, Jinhua, Zhejiang, Peoples R China
关键词
atherogenic index of plasma; cardiovascular-kidney-metabolic syndrome; cardiovascular disease; CHARLS; K-mean clustering analysis; PROFILE;
D O I
10.3389/fendo.2025.1540241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiovascular disease (CVD) is strongly correlated with plasma atherogenic index (AIP); however, there is limited literature exploring the association between trajectories of change in AIP and the risk of CVD. This study aimed to investigate whether changes in AIP are associated with CVD in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stage 0-3. Methods Data were sourced from the China Health and Retirement Longitudinal Study (CHARLS), aimed to compile high-quality microdata on individuals and households aged 45 and older in China. Change in AIP from 2012 to 2015 were classified employing K-means clustering analysis. Logistic regressions were employed to assess the association between different AIP change clusters and cumulative AIP and CVD incidence. Additionally, restricted cubic spline (RCS) regression was conducted to further evaluate the underlying linear relationship between cumulative AIP and CVD. Subgroup analyses were applied to verify the influence of confounding variables on the relationship between AIP and CVD. Weighted quantile sum (WGS) regressions were utilized to offer a comprehensive assessment of the overall effect. Results Out of 4,525 participants, 578 (12.77%) ultimately developed CVD within three years. Compared to cluster 1, which served as the best control for AIP, the odds ratio (OR) was 1.29 (1.02-1.62) for cluster 2, 1.33 (1.04-1.71) for cluster 3 and 1.35 (0.98-1.85) for cluster 4 after adjusting for several confounding variables. Categorizing the cumulative AIP into quartiles revealed an ascending trend (P for trend = 0.014). RCS regression disclosed a linear relationship between cumulative AIP and CVD. Further subgroup analyses revealed variations in these correlations modified by gender and Hukou status. WQS regression analysis highlighted the significance of triglyceride in the pathogenesis of CVD. Conclusions Significant changes in AIP are independently associated with the elevated risk of CVD in adults aged > 45 with CKM syndrome stage 0-3. Monitoring long-term fluctuations in AIP may aid in the early identification of individuals at high risk for CVD.
引用
收藏
页数:12
相关论文
共 36 条
[1]   Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome [J].
Alifu, Jiasuer ;
Xiang, Lanqing ;
Zhang, Wen ;
Qi, Penglong ;
Chen, Huiying ;
Liu, Lu ;
Yin, Guoqing ;
Mohammed, Abdul-Quddus ;
Lv, Xian ;
Shi, Tingting ;
Abdu, Fuad A. ;
Che, Wenliang .
CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
[2]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[3]   The plasma parameter log (TG/HDL-C) as an atherogenic index:: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). [J].
Dobiásová, M ;
Frohlich, J .
CLINICAL BIOCHEMISTRY, 2001, 34 (07) :583-588
[4]   Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography [J].
Dobiasova, Milada ;
Frohlich, Jiri ;
Sedova, Michaela ;
Cheung, Marian C. ;
Brown, B. Greg .
JOURNAL OF LIPID RESEARCH, 2011, 52 (03) :566-571
[5]   Unsupervised machine learning methods and emerging applications in healthcare [J].
Eckhardt, Christina M. ;
Madjarova, Sophia J. ;
Williams, Riley J. ;
Ollivier, Mattheu ;
Karlsson, Jon ;
Pareek, Ayoosh ;
Nwachukwu, Benedict U. .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2023, 31 (02) :376-381
[6]   Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J].
Ferrari, Alize J. ;
Santomauro, Damian Francesco ;
Aali, Amirali ;
Abate, Yohannes Habtegiorgis ;
Abbafati, Cristiana ;
Abbastabar, Hedayat ;
ElHafeez, Samar Abd ;
Abdelmasseh, Michael ;
Abd-Elsalam, Sherief ;
Abdollahi, Arash ;
Abdullahi, Auwal ;
Abegaz, Kedir Hussein ;
Zuniga, Roberto Ariel Abeldano ;
Aboagye, Richard Gyan ;
Abolhassani, Hassan ;
Abreu, Lucas Guimaraes ;
Abualruz, Hasan ;
Abu-Gharbieh, Eman ;
Abu-Rmeileh, Niveen M. E. ;
Ackerman, Ilana N. ;
Addo, Isaac Yeboah ;
Addolorato, Giovanni ;
Adebiyi, Akindele Olupelumi ;
Adepoju, Abiola Victor ;
Adewuyi, Habeeb Omoponle ;
Afyouni, Shadi ;
Afzal, Saira ;
Afzal, Sina ;
Agodi, Antonella ;
Ahmad, Aqeel ;
Ahmad, Danish ;
Ahmad, Firdos ;
Ahmad, Shahzaib ;
Ahmed, Ali ;
Ahmed, Luai A. ;
Ahmed, Muktar Beshir ;
Ajami, Marjan ;
Akinosoglou, Karolina ;
Akkaif, Mohammed Ahmed ;
Al Hasan, Syed Mahfuz ;
Alalalmeh, Samer O. ;
Al-Aly, Ziyad ;
Albashtawy, Mohammed ;
Aldridge, Robert W. ;
Alemu, Meseret Desalegn ;
Alemu, Yihun Mulugeta ;
Alene, Kefyalew Addis ;
Al-Gheethi, Adel Ali Saeed ;
Alharrasi, Maryam ;
Alhassan, Robert Kaba .
LANCET, 2024, 403 (10440) :2133-2161
[7]   Assessment of Cardiovascular Disease Risk [J].
Goldsborough III, Earl ;
Osuji, Ngozi ;
Blaha, Michael J. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (03) :483-509
[8]   Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults [J].
Hang, Fei ;
Chen, Jieruo ;
Wang, Zefeng ;
Zheng, Keyang ;
Wu, Yongquan .
LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
[9]   Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study [J].
Hu, Yaohua ;
Liang, Yu ;
Li, Jian ;
Li, Xinyang ;
Yu, Mengyuan ;
Cui, Wenpeng .
CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
[10]   Atherogenic index of plasma is related to coronary atherosclerotic disease in elderly individuals: a cross-sectional study [J].
Huang, Haomin ;
Yu, Xiaolong ;
Li, Lamei ;
Shi, Ganwei ;
Li, Feng ;
Xiao, Jianqiang ;
Yun, Zhihua ;
Cai, Gaojun .
LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)